房颤导管消融后痴呆风险降低:全国性队列研究
该研究基于韩国国民健康保险服务数据库,纳入2005至2015年间接受消融或药物治疗的房颤患者,经倾向评分匹配后比较两组痴呆发生风险。中位随访52个月,消融组总体痴呆发生率与风险均低于药物治疗组(HR 0.73,95%CI 0.58-0.93),且在消融成功者中更明显,消融失败者无显著差异。
要点
- 房颤患者接受导管消融与总体痴呆风险降低相关(HR 0.73)。
- 消融成功者痴呆风险降低更明显,消融失败者无显著差异。
- 排除卒中事件后关联仍存在(HR 0.76),提示非卒中机制。
核心结论
- 在房颤患者中,导管消融与药物治疗相比与痴呆风险降低相关,排除卒中后关联仍存在。
主要发现
- 中位随访52个月,消融组总体痴呆发生率为5.6/1000人年,药物治疗组为8.1/1000人年。
- 消融组总体痴呆风险低于药物治疗组(HR 0.73,95%CI 0.58-0.93)。
- 额外剔除卒中事件后,消融与痴呆风险的关联仍存在(HR 0.76,95%CI 0.61-0.95)。
- 消融成功者中关联更明显,消融失败者无显著差异。
- 消融与阿尔茨海默病和血管性痴呆等亚型风险降低相关。
临床怎么用
- 对于房颤患者,导管消融可能不仅改善节律相关症状,还与降低痴呆风险相关,尤其消融成功者可能获益更明显。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Accumulating evidence shows that atrial fibrillation (AF) is associated with an increased risk of dementia. Catheter ablation for AF prolongs the duration of sinus rhythm, thereby improving the quality of life. We investigated the association of catheter ablation for AF with the occurrence of dementia. METHODS AND RESULTS: Using the Korean National Health Insurance Service database, among 194 928 adults with AF treated with ablation or medical therapy (antiarrhythmic or rate control drugs) between 1 January 2005 and 31 December 2015, we studied 9119 patients undergoing ablation and 17 978 patients managed with medical therapy. The time-at-risk was counted from the first medical therapy, and ablation was analysed as a time-varying exposure. Propensity score-matching was used to correct for differences between the groups. During a median follow-up of 52 months, compared with patients with medical therapy, ablated patients showed lower incidence and risk of overall dementia (8.1 and 5.6 per 1000 person-years, respectively; hazard ratio 0.73, 95% confidence interval 0.58-0.93). The associations between ablation and dementia risk were consistently observed after additionally censoring for incident stroke (hazard ratio 0.76, 95% confidence interval 0.61-0.95) and more pronounced in cases of ablation success whereas no significant differences observed in cases of ablation failure. Ablation was associated with lower risks of dementia subtypes including Alzheimer's disease and vascular dementia. CONCLUSION: In this nationwide cohort of AF patients treated with catheter ablation or medical therapy, ablation was associated with decreased dementia risk. This relationship was evident after censoring for stroke and adjusting for clinical confounders.
引用
- Kim D, Yang PS, Sung JH, et al. Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study. Eur Heart J. 2020. PMID: 33022705. doi:10.1093/eurheartj/ehaa726
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。